What is the full form of ASD in pharma?
•
3 min read
According to research, nearly 90% of new chemical entities in the drug development pipeline are poorly water-soluble, creating a significant challenge for effective oral medication. To address this, the full form of ASD in pharma most commonly refers to **Amorphous Solid Dispersion**, a sophisticated formulation strategy that improves drug performance and bioavailability.
